December 2018 News Round Up


North Korea ‘tests ultramodern tactical weapon’ North Korean leader Kim Jong Un has overseen the testing of a “newly developed ultramodern tactical weapon”, Pyongyang’s state media reported Friday, in a move that will raise the temperature over denuclearisation talks.
Heysham 1: Three hurt in nuclear plant accident A release of steam at a British nuclear power plant injured three workers on Monday but there was no risk to the public and the incident was now under control, operator EDF Energy said.
Anti-vaccine community behind North Carolina chickenpox outbreak A chickenpox outbreak at a private school now ranks as the state’s largest since a vaccine for the virus became available more than 20 years ago, health officials say.
Over 350 cracks found in Hunterston B nuclear reactor More than 350 cracks have been discovered in an ageing nuclear power reactor at Hunterston in North Ayrshire, breaching an agreed safety limit and prompting calls for a permanent shutdown.
Inside Sellafield’s death zone with the nuclear clean-up robots The Thorp nuclear reprocessing plant at Sellafield, Cumbria, has recycled its final batch of reactor fuel. But it leaves behind a hugely toxic legacy for future generations to deal with. So how will it be made safe?
Ebola outbreak in DR Congo now second worst in history The UN’s global health body says the Ebola outbreak in the east of the Democratic Republic of Congo is now the second-biggest ever recorded.
Democratic Republic of the Congo begins first-ever multi-drug Ebola trial The Ministry of Health of the Democratic Republic of the Congo (DRC) today announced that a randomized control trial has begun to evaluate the effectiveness and safety of drugs used in the treatment of Ebola patients.

Explosion at chemical factory in China kills 22, injures 22
An explosion near a chemical plant in China’s northern Hebei province early on Wednesday killed 22 people and injured at least 22 others.
How the global trade in tear gas is booming
On the surface, Noor Noor and Terry Burns don’t have much in common. The former is a 28-year-old student at Cambridge, getting a degree in environmental conservation that he plans to use back home in Cairo, Egypt.
Uncovering secret structure to safer explosives A team of scientists at Lawrence Livermore National Laboratory (LLNL) has shown that the structure of microscopic pores in high explosive materials can significantly impact performance and safety.
U.S. gives Russia 60 days to comply with nuclear treaty The United States delivered Russia a 60-day ultimatum on Tuesday to come clean about what Washington says is a violation of a arms control treaty that keeps missiles out of Europe, saying only Moscow could save the pact.
US accuses Russia, Syria of lying about Aleppo ‘chemical attack’ The United States and Britain have accused Russia of fabricating a story about chemical weapons use by Syrian rebels.
Charlie Rowley: Novichok victim ‘terrified’ about health A survivor of the Salisbury Novichok attack fears the poison is slowly killing him. Speaking for the first time since battling meningitis, Charlie Rowley, 45, tells how he is losing his sight, has heart trouble and has had a series of strokes.
‘Miracle’ six-day-old baby survives Ebola A baby girl who was diagnosed with Ebola when she was only six days old has survived, health officials in the Democratic Republic of the Congo have confirmed.


Lyndra Scientists Develop Ultra Long-Acting Oral Drug Delivery Platform Lyndra, a healthcare company developing ultra long-acting oral drug delivery technologies, announced the publication of a scientific paper describing its novel technology in one of its earliest applications.
Successful second round of experiments with Wendelstein 7-X Fusion Device The experiments conducted from July until November at the Wendelstein 7-X fusion device at the Max Planck Institute for Plasma Physics (IPP) in Greifswald have achieved higher values for the density and the energy content of the plasma and long discharge times of up to 100 seconds – record results for devices of the stellarator type.
Budget biosensor detects infections in real time Using a small and inexpensive biosensor, researchers at UBC Okanagan, in collaboration with the University of Calgary, have built a diagnostic tool that provides health care practitioners almost instant diagnosis of a bacterial infection.
Researchers call on Iron Man for nuclear workwear inspiration If wearable technologies are the future, a radioactive-busting robotic suit could represent yet one more dramatic step into the beyond.
Motion-powered electric bandage speeds healing by zapping wounds A new, low-cost wound dressing developed by University of Wisconsin–Madison engineers could dramatically speed up healing in a surprising way. The method leverages energy generated from a patient’s own body motions to apply gentle electrical pulses at the site of an injury.
New mask to protect military aircrews against weapons of mass destruction In November 2018, the Air Force will complete fielding of an improved Chemical, Biological, Radiological and Nuclear protective mask for aircrew on rotary wing aircraft, allowing operational units to achieve Full Operational Capability.
Essential Oils From Garlic and Other Herbs and Spices Kill “Persister” Lyme Disease Bacteria Oils from garlic and several other common herbs and medicinal plants show strong activity against the bacterium that causes Lyme disease, according to a study by researchers at Johns Hopkins Bloomberg School of Public Health. These oils may be especially useful in alleviating Lyme symptoms that persist despite standard antibiotic treatment, the study also suggests.
Promising antibiotic derived from wasp venom The venom of insects such as wasps and bees is full of compounds that can kill bacteria. Unfortunately, many of these compounds are also toxic for humans, making it impossible to use them as antibiotic drugs.

Throughout the CBRN Europe website there are links to other external websites. Whilst every effort is made to ensure that these website content is suitable, CBRN Europe cannot be held responsible for the content of these external site